Authors:
SCHWARTZ SM
DALING JR
DOODY DR
WIPF GC
CARTER JJ
MADELEINE MM
MAO EJ
FITZGIBBONS ED
HUANG SX
BECKMANN AM
MCDOUGALL JK
GALLOWAY DA
Citation: Sm. Schwartz et al., ORAL-CANCER RISK IN RELATION TO SEXUAL HISTORY AND EVIDENCE OF HUMAN-PAPILLOMAVIRUS INFECTION, Journal of the National Cancer Institute, 90(21), 1998, pp. 1626-1636
Authors:
MADELEINE MM
DALING JR
CARTER JJ
WIPF GC
SCHWARTZ SM
MCKNIGHT B
KURMAN RJ
BECKMANN AM
HAGENSEE ME
GALLOWAY DA
Citation: Mm. Madeleine et al., COFACTORS WITH HUMAN-PAPILLOMAVIRUS IN A POPULATION-BASED STUDY OF VULVAR CANCER, Journal of the National Cancer Institute, 89(20), 1997, pp. 1516-1523
Authors:
DALING JR
MADELEINE MM
MCKNIGHT B
CARTER JJ
WIPF GC
ASHLEY R
SCHWARTZ SM
BECKMANN AM
HAGENSEE ME
MANDELSON MT
GALLOWAY DA
Citation: Jr. Daling et al., THE RELATIONSHIP OF HUMAN PAPILLOMAVIRUS-RELATED CERVICAL TUMORS TO CIGARETTE-SMOKING, ORAL-CONTRACEPTIVE USE, AND PRIOR HERPES-SIMPLEX VIRUS TYPE-2 INFECTION, Cancer epidemiology, biomarkers & prevention, 5(7), 1996, pp. 541-548
Authors:
CHRISTENSEN ND
DILLNER J
EKLUND C
CARTER JJ
WIPF GC
REED CA
CLADEL NM
GALLOWAY DA
Citation: Nd. Christensen et al., SURFACE CONFORMATIONAL AND LINEAR EPITOPES ON HPV-16 AND HPV-18 L1 VIRUS-LIKE PARTICLES AS DEFINED BY MONOCLONAL-ANTIBODIES, Virology, 223(1), 1996, pp. 174-184
Authors:
CARTER JJ
KOUTSKY LA
WIPF GC
CHRISTENSEN ND
LEE SK
KUYPERS J
KIVIAT N
GALLOWAY DA
Citation: Jj. Carter et al., THE NATURAL-HISTORY OF HUMAN PAPILLOMAVIRUS TYPE-16 CAPSID ANTIBODIESAMONG A COHORT OF UNIVERSITY WOMEN, The Journal of infectious diseases, 174(5), 1996, pp. 927-936
Authors:
GALLOWAY DA
CARTER JJ
WIPF G
HAGENSEE ME
LI LF
LEE SK
KUYPERS J
WATTS DH
HOLMES KK
KOUTSKY LA
KIVIAT N
Citation: Da. Galloway et al., DIAGNOSIS OF HUMAN PAPILLOMAVIRUS INFECTION BY DETECTION OF VIRAL-DNAAND BY SEROLOGY, Journal of cellular biochemistry, 1995, pp. 251-251
Authors:
HAGENSEE ME
CARTER JJ
WIPF GC
GALLOWAY DA
Citation: Me. Hagensee et al., IMMUNIZATION OF MICE WITH HPV VACCINIA VIRUS RECOMBINANTS GENERATES SERUM IGG, IGM, AND MUCOSAL IGA ANTIBODIES, Virology, 206(1), 1995, pp. 174-182
Authors:
CARTER JJ
WIPF GC
HAGENSEE ME
MCKNIGHT B
HABEL LA
LEE SK
KUYPERS J
KIVIAT N
DALING JR
KOUTSKY LA
WATTS DH
HOLMES KK
GALLOWAY DA
Citation: Jj. Carter et al., USE OF HUMAN PAPILLOMAVIRUS TYPE-6 CAPSIDS TO DETECT ANTIBODIES IN PEOPLE WITH GENITAL WARTS, The Journal of infectious diseases, 172(1), 1995, pp. 11-18
Authors:
MADELEINE MM
DALING JR
CARTER JJ
HAGENSEE ME
WIPF GC
GALLOWAY DA
MCKNIGHT B
Citation: Mm. Madeleine et al., RISK OF VULVAR CANCER-ASSOCIATED WITH HPV-16 L1 ANTIBODY AND SMOKING, American journal of epidemiology, 141(11), 1995, pp. 78-78
Authors:
CARTER JJ
HAGENSEE MB
LEE SK
MCKNIGHT B
KOUTSKY LA
GALLOWAY DA
Citation: Jj. Carter et al., USE OF HPV-1 CAPSIDS PRODUCED BY RECOMBINANT VACCINIA VIRUSES IN AN ELISA TO DETECT SERUM ANTIBODIES IN PEOPLE WITH FOOT WARTS, Virology, 199(2), 1994, pp. 284-291
Authors:
CARTER JJ
HAGENSEE M
TAFLIN MC
LEE SK
KOUTSKY LA
GALLOWAY DA
Citation: Jj. Carter et al., HPV-1 CAPSIDS EXPRESSED IN-VITRO DETECT HUMAN SERUM ANTIBODIES ASSOCIATED WITH FOOT WARTS, Virology, 195(2), 1993, pp. 456-462